Clinical Trial

Safety and Efficacy of CD19 CAR-T/CAR-NK Cells

Name: Safety and Efficacy of CD19 CAR-T/CAR-NK Cells — clinical trial record (NCT06596057)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Early Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated September 19, 2024 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Summary

To investigate the safety and efficacy of CD19 CAR-T/CAR-NK cells in patients with relapsed/refractory B-cell lymphoma and acute B-lymphoblastic leukemia.

Trial Details

NCT Number	NCT06596057
Lead Sponsor	The Second Hospital of Shandong University
Conditions	Safety and Efficacy
Enrollment	10 participants
Start Date	2024-02-10
Primary Completion	2026-06 (estimated)
Study Completion	2026-06 (estimated)
Updated on ClinicalTrials.gov	2024-09-19